Records from the Office of National Drug Control Policy in response to American Oversight's request for communications between Pain Management Best Practices Inter-Agency Task Force member and drug and device manufacturers.

Records from the Office of National Drug Control Policy in response to American Oversight's request for communications related to the opioid epidemic between with Kellyanne Conway or anyone acting on Ms. Conway’s behalf, including Ms. Conway’s Chief.

The Office of National Drug Control Policy stated that it had no records of communications with lobbyist Matthew Schlapp, or his lobbying firm Cove Strategies, regarding the opioid crisis and drug pricing.

Special Counsel Robert Mueller made his long-awaited and much-anticipated appearance before Congress on Wednesday.

FOIA to the Office of National Drug Control Policy seeking email communications between Pain Management Best Practices Inter-Agency Task Force member and drug and device manufacturers.

Office of National Drug Control Policy emails and records regarding substantive information about the opioid crisis during 2017.

FOIA to the Executive Office of the President's Office of National Drug Control Policy (ONDCP) seeking communications with Matt Schlapp or with his lobbying firm Cove Strategies—which has registered new clients since President Trump took office and has contacted agencies regarding the opioid crisis and drug pricing.

Office of National Drug Control Policy resumes of political appointees.

FOIA to Office of National Drug Control Policy seeking resumes, job titles, SF-50s, and ethics waivers for political appointees who joined the administration or were assigned to new positions after the date of American Oversight’s previous request for this information submitted in late 2017.

No records response from ONDCP in response to our FOIA for communications with the opioid industry. (ONDCP-18-0147)